Some studies have shown that some missense mutations in p53 not only deactivate the tumor suppressor function of p53, but also acquire novel oncogenic functions such as tumor cell proliferation, antiapoptotic effects, and promotion of angiogenesis and metastasis formation. The gene discussed is TP53; the disease is neoplasm.